BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

696 related articles for article (PubMed ID: 9309090)

  • 21. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Preoperative radiochemotherapy in esophageal carcinoma].
    Stahl M
    Praxis (Bern 1994); 1996 Mar; 85(10):303-6. PubMed ID: 8628959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neoadjuvant and adjuvant chemotherapy for esophageal adenocarcinoma.
    Mooney MM
    J Surg Oncol; 2005 Dec; 92(3):230-8. PubMed ID: 16299790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved local control by surgery and paclitaxel-based chemoradiation for esophageal squamous cell carcinoma: results of a retrospective non-randomized study.
    Hsu FM; Lin CC; Lee JM; Chang YL; Hsu CH; Tsai YC; Lee YC; Cheng JC
    J Surg Oncol; 2008 Jul; 98(1):34-41. PubMed ID: 18449912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preoperative concurrent chemotherapy and radiation therapy followed by surgery for esophageal cancer.
    Yano M; Inoue M; Shiozaki H
    Ann Thorac Cardiovasc Surg; 2002 Jun; 8(3):123-30. PubMed ID: 12472392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Locally advanced non inflammatory breast cancer treated by combined chemotherapy and preoperative irradiation: updated results in a series of 120 patients].
    Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J
    Cancer Radiother; 2004 Jun; 8(3):155-67. PubMed ID: 15217583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. REG I expression predicts long-term survival among locally advanced thoracic squamous cell esophageal cancer patients treated with neoadjuvant chemoradiotherapy followed by esophagectomy.
    Motoyama S; Sugiyama T; Ueno Y; Okamoto H; Takasawa S; Nanjo H; Watanabe H; Maruyama K; Okuyama M; Ogawa J
    Ann Surg Oncol; 2006 Dec; 13(12):1724-31. PubMed ID: 17009160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myelotoxicity of preoperative chemoradiotherapy is a significant determinant of poor prognosis in patients with T4 esophageal cancer.
    Miyoshi N; Yano M; Takachi K; Kishi K; Noura S; Eguchi H; Yamada T; Miyashiro I; Ohue M; Ohigashi H; Sasaki Y; Ishikawa O; Doki Y; Imaoka S
    J Surg Oncol; 2009 Apr; 99(5):302-6. PubMed ID: 19170110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Radiotherapy for locally advanced esophageal cancer].
    Fukuhara N; Karasawa K; Kaneyasu Y; Kita-Okawa M; Okawa T
    Gan To Kagaku Ryoho; 1998 Oct; 25(12):1841-8. PubMed ID: 9797806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant radiotherapy and radiochemotherapy in the management of esophageal cancer: a review of the literature.
    Carcaterrra M; Osti MF; De Sanctis V; Caruso C; Berardi F; Enrici RM
    Rays; 2005; 30(4):319-22. PubMed ID: 16792007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Postoperative adjuvant therapies for esophageal carcinoma].
    Kuwano H; Ojima H; Kato H
    Gan To Kagaku Ryoho; 2000 Nov; 27(13):2023-7. PubMed ID: 11103232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical aspects of multimodality therapy for resectable locoregional esophageal cancer.
    Shinoda M; Hatooka S; Mori S; Mitsudomi T
    Ann Thorac Cardiovasc Surg; 2006 Aug; 12(4):234-41. PubMed ID: 16977291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neoadjuvant chemoradiation versus chemotherapy for patients undergoing esophagectomy for esophageal cancer.
    Luu TD; Gaur P; Force SD; Staley CA; Mansour KA; Miller JI; Miller DL
    Ann Thorac Surg; 2008 Apr; 85(4):1217-23; discussion 1223-4. PubMed ID: 18355499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neoadjuvant therapy of esophageal carcinoma.
    Reed CE
    Chest Surg Clin N Am; 1994 May; 4(2):299-314. PubMed ID: 8049998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of neoadjuvant therapy for esophageal adenocarcinoma.
    Ku GY; Ilson DH
    Surg Oncol Clin N Am; 2009 Jul; 18(3):533-46. PubMed ID: 19500742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Making sense of multimodality therapy for esophageal cancer.
    Krasna MJ; Mao YS
    Surg Oncol Clin N Am; 1999 Apr; 8(2):259-78. PubMed ID: 10339645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neoadjuvant therapy for esophageal cancer: surgical considerations.
    Piraino A; Vita ML; Tessitore A; Cusumano G; Congedo MT; Margaritora S; Porziella V; Meacci E; Cesario A; Granone P
    Rays; 2006; 31(1):37-45. PubMed ID: 16999374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neoadjuvant chemotherapy for local advanced breast cancer with stage IIIB.
    Kim R; Osaki A; Tanabe K; Toge T
    Oncol Rep; 2004 Jun; 11(6):1265-72. PubMed ID: 15138565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Progress of postoperative adjuvant therapies for esophageal cancer].
    Terashima M; Kogure M; Gotoh M
    Gan To Kagaku Ryoho; 2002 Dec; 29(13):2475-80. PubMed ID: 12506469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Long-term results of chemoradiation therapy for the patients with locally advanced (T4) esophageal cancer].
    Sekikawa K; Onogi H; Yazawa T; Sato Y; Sakamoto W; Miyamoto K; Fujita S; Suzuki S; Endo Y; Ohki S; Takenoshita S
    Gan To Kagaku Ryoho; 2006 Sep; 33(9):1253-6. PubMed ID: 16969020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.